Dr. Kadalmani Krishnan

               Founder & CEO

              Ph.D., University of Cambridge, UK
              Post-doctoral Fellow, Harvard University, USA

             Biochemist with 20+ years of experience in product               development, GMP manufacturing, Pre-clinical and                 clinical trials.
              
LinkedIn

             Dr. Anita Chugh

              Co-Founder & CSO

              Ph.D., AIIMS, Delhi, India
              Post-doctoral Fellow, McMaster University, Canada

              Pharmacologist with 30+ years of experience in                      Technology Development, Drug Discovery Large &                Small Molecules, Patenting & Licensing
               
LinkedIn

Major Achievements

55
Publications

$13M
Grants

20+
Awards

02
Books

The scientific leadership team is at the forefront of innovation, with a proven track record of advancing transformative R&D across biotechnology and healthcare. With deep expertise in academia, industry, and education, we consistently deliver impactful, life-changing products and services.

The team is skilled in turning R&D insights into actionable solutions. We have extensive experience in designing cutting-edge R&D facilities, mentoring and training scientists, and leading teams of up to 200 professionals. Our leadership has successfully launched multiple products, overseen discovery manufacturing, and led greenfield projects, converting scientific advancements into tangible healthcare products. Navigating India’s complex regulatory landscape is a strength, and we work closely with regulatory authorities to streamline approval processes, ensuring compliance with the highest standards.

The team is recognized by the scientific community, with a high citation index and roles in prestigious Expert Working Groups, such as the Biotechnology Derived Therapeutic Products Committee with the Indian Pharmacopoeia Commission (IPC). We are members of the Advisory Committee, Advance Industrial Training Program of RCB Regional Centre for Biotechnology (RCB), Govt. of India. Also, a panel member for exploring the regulatory barriers of conducting first-in-human phase 1 clinical trials in India – a Delphi study, ICMR.

Through education and continuous knowledge sharing, we drive innovation and impact patient care with lasting results — translating groundbreaking discoveries into real-world applications, improving patient care globally.